2021 Investor Day
Speaker Biographies
Brett Sandercock
Chief Financial Officer
Brett Sandercock was appointed chief financial officer in January 2006. Previously, he served as ResMed's vice president of
treasury and finance from November 2004 until December 2005, and group accountant and controller from 1998 to 2004.
Before joining ResMed, Mr. Sandercock was manager of financial accounting and group reporting at Norton Abrasives, a division
of Saint-Gobain, a French multinational corporation, from 1996 to 1998. He also held finance and accounting roles from 1994 to
1996 at Health Care of Australia, a large private hospital operator. From 1989 to 1994, he worked at Pricewaterhouse Coopers in
Sydney, specializing in audits of clients across distribution and manufacturing, financial services, technology, and other
industries.
From June 2019 to August 2021, Mr. Sandercock served as non-executive chair of the board of directors of Osteopore Limited
(ASX:OSX), an Australian and Singapore based medical technology company, commercializing products used for the
regeneration of bone across a range of therapeutic areas.
Mr. Sandercock holds a Bachelor degree in economics from Macquarie University in Sydney, and is a certified chartered
accountant.
O2021 ResMed | 2021 Investor Day – Sept 8, 2021
-
98View entire presentation